U.S. News hospital rankings delayed due to data errors

The annual hospital rankings from U.S. News and World Report will now be released a week later than scheduled after errors were discovered in data which affected 12 “data-driven specialty rankings.”

This data had already been used in the rankings released to hospitals on July 11. A public release had been scheduled on August 1, but that’s now been pushed back to August 8 to give U.S. News time to review the data and release corrected rankings to hospitals first.

“While these changes … allow us to better assess hospital care, they are complex to implement and we discovered errors late in the process,” U.S. News said in an email, which was sent to participating hospitals and obtained by STAT News. “We are confident that once correctly implemented these changes will benefit our shared goal of providing patients with better information about their health care.”

Methodology behind this year’s rankings has been revised to better for the socioeconomic status of patients served by a hospital, as well as evaluating “the care of low-income patients, patient safety and hospitals that accept very sick patients from other hospitals.” U.S. News didn’t say whether those changes caused any of the data errors which led to the delay.

In the 2016 report, Mayo Clinic topped the rankings, taking the top spot from Boston’s Massachusetts General Hospital.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.